Gray matter pathology and multiple sclerosis

Current Neurology and Neuroscience Reports

Volumn 9, Issue 5, 2009, Pages 399-404

  Wegner, Christiane ^a   Stadelmann, Christine ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR;

ALLERGIC ENCEPHALOMYELITIS; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN CORTEX LESION; CELL AGGREGATION; CELL LOSS; CEREBELLUM; DEMYELINATING DISEASE; EXCITOTOXICITY; GRAY MATTER; HIPPOCAMPUS; HUMAN; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; REMYELINIZATION; REVIEW; SPINAL CORD; WHITE MATTER;

ANIMALS; CEREBELLAR CORTEX; CEREBRAL CORTEX; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE DEGENERATION; NERVE FIBERS, MYELINATED; SPINAL CORD;

EID: 68449088147     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-009-0058-x     Document Type: Review

References (50)

1. Brownell B, Hughes JT: Distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962, 25:315-320.
2. Lumsden CE: The neuropathology of multiple sclerosis. In Handbook of Clinical Neurology. Edited by Vinken PJ, Bruyn GW. Amsterdam: North-Holland; 1970:217-309.
3. Wegner C, Esiri MM, Chance SA, et al.: Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006, 67:960-967.
4. Albert M, Antel J, Bruck W, et al.: Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol 2007, 17:129-138.
5. Bo L, Vedeler CA, Nyland HI, et al.: Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003, 62:723-732.
6. Peterson JW, Bo L, Mork S, et al.: Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001, 50:389-400.
7. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al.: Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128:2705-2712.
8. Magliozzi R, Howell O, Vora A, et al.: Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007, 130:1089-1104.
9. Serafini B, Rosicarelli B, Franciotta D, et al.: Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007, 204:2899-2912.
10. Moll NM, Rietsch AM, Ransohoff AJ, et al.: Cortical demyelination in PML and MS: Similarities and differences. Neurology 2008, 70:336-343.
11. Bo L, Vedeler CA, Nyland H, et al.: Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003, 9:323-331.
12. Brink BP, Veerhuis R, Breij EC, et al.: The pathology of multiple sclerosis is location-dependent: No significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 2005, 64:147-155.
13. van Horssen J, Brink BP, de Vries HE, et al.: The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 2007, 66:321-328.
14. Pomeroy I, Matthews PM, Frank JA, et al.: Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain 2005, 128:2713-2721.
15. Merkler D, Ernsting T, Kerschensteiner M, et al.: A new focal EAE model of cortical demyelination: Multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain 2006, 129:1972-1983.
16. Storch MK, Bauer J, Linington C, et al.: Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatability complex (MHC) haplotype-related. J Neuropathol Exp Neurol 2006, 65:1137-1142.
17. Merkler D, Boscke R, Schmelting B, et al.: Differential macrophage/ microglia activation in neocortical EAE lesions in the marmoset monkey. Brain Pathol 2006, 16:117-123.
18. Neumann H: Control of glial immune function by neurons. Glia 2001, 36:191-199.
19. Patrikios P, Stadelmann C, Kutzelnigg A, et al.: Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006, 129:3165-3172.
20. Noble M, Arhin A, Gass D, Mayer-Proschel M: The cortical ancestry of oligodendrocytes: Common principles and novel features. Dev Neurosci 2003, 25:217-233.
21. Vercellino M, Plano F, Votta B, et al.: Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005, 64:1101-1107.
22. Vercellino M, Merola A, Piacentino C, et al.: Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: Correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 2007, 66:732-739.
23. Dutta R, McDonough J, Yin X, et al.: Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006, 59:478-489.
24. Cifelli A, Arridge M, Jezzard P, et al.: Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002, 52:650-653.
25. Dutta R, McDonough J, Chang A, et al.: Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients. Brain 2007, 130:2566-2576.
26. Sailer M, Fischl B, Salat D, et al.: Focal thinning of the cerebral cortex in multiple sclerosis. Brain 2003, 126:1734-1744.
27. De Stefano N, Matthews PM, Filippi M, et al.: Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability. Neurology 2003, 60:1157-1162.
28. Geurts JJ, Bo L, Roosendaal SD, et al.: Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007, 66:819-827.
29. Papadopoulos D, Dukes S, Patel R, et al.: Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol 2009, 19:238-253.
30. Evangelou N, Konz D, Esiri, MM, et al.: Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 2001, 124:1813-1820.
31. Gilmore CP, Donaldson I, Bo L, et al.: Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: A comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 2009, 80:182-187.
32. Kutzelnigg A, Faber-Rod JC, Bauer J, et al.: Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007, 17:38-44.
33. Gilmore CP, Bo L, Owens T, et al.: Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology. Brain Pathol 2006, 16:202-208.
34. Gilmore CP, Deluca GC, Bo L, et al.: Spinal cord neuronal pathology in multiple sclerosis. Brain Pathol 2008 Dec 19 (Epub ahead of print).
35. Hampton DW, Anderson J, Pryce G, et al.: An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss. J Neuroimmunol 2008, 201-202:200-211.
36. Zhu B, Luo L, Moore GR, et al.: Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. Am J Pathol 2003, 162:1639-1650.
37. Bannermann R, Hahn A, Ramirez S, et al.: Motor neuron pathology in experimental autoimmune encephalomyelitis: Studies in THYI-YFP transgenic mice. Brain 2005, 128:1877-1886.
38. Kidd D, Barkhof F, McConnell R, et al.: Cortical lesions in multiple sclerosis. Brain 1999, 122:17-26.
39. Geurts JJ, Bo L, Pouwels PJ, et al.: Cortical lesions in multiple sclerosis: Combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005, 26:572-577.
40. Kangarlu A, Bourekas EC, Ray-Chaudhury A, Rammohan KW: Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. AJNR Am J Neuroradiol 2007, 28:262-266.
41. Geurts JJ, Pouwels PJ, Uitdehaag BM, et al.: Intracortical lesions in multiple sclerosis: Improved detection with 3D double inversion-recovery MR imaging. Radiology 2005, 236:254-260.
42. Calabrese M, De SN, Atzori M, et al.: Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007, 64:1416-1422.
43. Metcalf M, Xu D, Okuda DT, et al.: High-resolution phased-array MRI of the human brain at 7 Tesla: Initial experience in multiple sclerosis patients. J Neuroimaging 2009 Jan 29 (Epub ahead of print).
44. Calabrese M, Filippi M, Rovaris M, et al.: Evidence for relative cortical sparing in benign multiple sclerosis: A longitudinal magnetic resonance imaging study. Mult Scler 2009, 15:36-41.
45. Calabrese M, De Stefano N, Atzori M, et al.: Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. J Neurol 2008, 255:581-586.
46. Dalton CM, Chard DT, Davies GR, et al.: Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004, 127:1101-1107.
47. Tiberio M, Chard DT, Altmann DR, et al.: Gray and white matter volume changes in early RRMS: A 2-year longitudinal study. Neurology 2005, 64:1001-1007.
48. Chard DT, Griffin CM, McLean MA, et al.: Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002, 125:2342-2352.
49. Davies GR, Ramio-Torrenta L, Hadjiprocopis A, et al.: Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2004, 75:998-1002.
50. Sepulcre J, Goni J, Masdeu JC, et al.: Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: Evidence from voxel-based analysis of T1 lesions in the visual pathway. Arch Neurol 2009, 66:173-179.